New York, NY – September 26, 2025 – Gold prices are demonstrating remarkable resilience, holding firmly above the $3,750 per ounce mark today, fueled by a confluence of factors including ongoing geopolitical uncertainties and a U.S. core Personal Consumption Expenditures (PCE) price index that remains stubbornly elevated at 2.9%
Over the past six months, Thermo Fisher’s shares (currently trading at $457.50) have posted a disappointing 10.9% loss, well below the S&P 500’s 15.7% gain. This might have investors contemplating their next move.
The third quarter of 2025 has etched itself into financial history, witnessing the U.S. stock market surge to unprecedented heights. The benchmark S&P 500 (SPX) decisively crossed the 6,500 threshold, ultimately closing above 6,600 points, while the Dow Jones Industrial Average (DJI) powered past 46,000.
The global economic landscape is witnessing a notable divergence in inflationary pressures, with much of the world experiencing a moderation in price increases, while the United States grapples with stubbornly high inflation rates. This disparity is not merely a cyclical anomaly but a consequence of distinct domestic policies, particularly tariffs
Shares of life sciences company Thermo Fisher (NYSE:TMO)
jumped 2.7% in the afternoon session after Barclays upgraded the stock to Overweight from Equalweight and boosted its price target, citing a more attractive valuation and clearer growth outlook.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth.
This has capped the upside for healthcare stocks lately as the industry’s flat return over the past six months has trailed the S&P 500’s 17.4% gain.
Concerns are escalating over the Federal Reserve's long-standing independence as political pressure intensifies, raising fundamental questions about the future of U.S. monetary policy and its implications for financial markets. Recent actions from the executive branch, including an attempted dismissal of a sitting Fed governor and the nomination of individuals
Despite widespread market expectations for a September interest rate cut, the Federal Reserve finds itself navigating a perilous economic landscape marked by persistently high inflation. Stubbornly "sticky" services inflation, coupled with the escalating impact of new tariffs on core goods, is creating a complex dilemma for policymakers. While a cooling
RBC Capital upgraded Bio-Techne, citing M&A confidence, margin gains, and growth potential after a sharp stock drop and alignment with sector valuations.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
The U.S. economy finds itself at a critical juncture, exhibiting a robust rebound in Gross Domestic Product (GDP) growth while simultaneously grappling with persistent and, in some areas, accelerating inflationary pressures. This complex interplay of economic indicators, including the Personal Consumption Expenditures (PCE) index, Consumer Price Index (CPI), Producer
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Thermo Fisher (NYSE:TMO) and its peers.
